US 11,702,424

Application 16/996,117 · Granted Jul 18, 2023

Bicyclic-fused heteroaryl or aryl compounds

Estimated expiration

April 3, 2035

8y 135d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Apr 3, 2015
+ 20 years
Apr 3, 2035
PTA +169d
Sep 19, 2035
TD cap (US 10,329,302)
Apr 3, 2035
Final
Apr 3, 2035

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
August 18, 2020
Earliest effective filing
April 3, 2015
Issue date
July 18, 2023
PTA
+169 days
Base expiry (before PTA)
April 3, 2035

April 3, 2015 + 20 years = April 3, 2035 + 169 PTA days = September 19, 2035

  • Continuation of application 16/411,679, filed May 14, 2019, issued as US 10,793,579
  • Continuation of application 15/862,691, filed Jan 5, 2018, issued as US 10,329,302
  • Continuation of application 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
  • Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
  • Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
  • Continuation of application 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
  • Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
  • Continuation of application 15/862,691, filed Jan 5, 2018, issued as US 10,329,302
  • Continuation of application 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
  • Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
  • PRO61/975,473 — Provisional — not used for base term
  • PRO61/975,473 — Provisional — not used for base term
  • PRO61/975,473 — Provisional — not used for base term
  • PRO61/975,473 — Provisional — not used for base term
  • PRO61/975,473 — Provisional — not used for base term

Terminal disclaimers

TD approved2 approved, 4 filed

TD caps expiration to April 3, 2035 (earliest expiring referenced patent: US 10,329,302)

  • US 10,329,302· Application 15/862,691Capping patent

    Bicyclic-fused heteroaryl or aryl compounds

    Filing date
    Jan 5, 2018
    Earliest effective filing
    Apr 3, 2015
    Issue date
    Jun 25, 2019
    PTA
    0 days
    Calculated expiration
    Apr 3, 2035

    Continuation of 15/232,892, filed Aug 10, 2016, issued as US 9,879,022

    Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168

    Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168

    Apr 3, 2015 + 20y = Apr 3, 2035

  • US 9,879,022· Application 15/232,892

    Bicyclic-fused heteroaryl or aryl compounds

    Filing date
    Aug 10, 2016
    Earliest effective filing
    Apr 3, 2015
    Issue date
    Jan 30, 2018
    PTA
    0 days
    Calculated expiration
    Apr 3, 2035

    Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168

    Apr 3, 2015 + 20y = Apr 3, 2035

  • US 10,793,579· Application 16/411,679

    Bicyclic-fused heteroaryl or aryl compounds

    Filing date
    May 14, 2019
    Earliest effective filing
    Apr 3, 2015
    Issue date
    Oct 6, 2020
    PTA
    0 days
    Calculated expiration
    Apr 3, 2035

    Continuation of 15/862,691, filed Jan 5, 2018, issued as US 10,329,302

    Continuation of 15/232,892, filed Aug 10, 2016, issued as US 9,879,022

    Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168

    Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168

    Continuation of 15/232,892, filed Aug 10, 2016, issued as US 9,879,022

    Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168

    Apr 3, 2015 + 20y = Apr 3, 2035

Notes (1)

  • [TD_DOCS_TRUNCATED] Found 4 filed TD documents; parsing first 3 only

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 16/996,117 · US 11,702,424

PatentReply compiles the prosecution history behind US 11,702,424: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11702424

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.